Global Infantile Spasms Therapeutics Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 159251
- Pages: 150
-
Format:
Summary
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global Infantile Spasms Therapeutics market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Oral
Injection
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
H. Lundbeck
Mallinckrodt
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital
Clinic
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Infantile Spasms Therapeutics of Research
1.1.1 Definition
1.1.2 Specifications of Infantile Spasms Therapeutics
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Oral Overview
1.2.1.2 Injection Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Hospital
1.3.1.2 Clinic
1.3.1.3 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Oral Market Size 2018-2023
3.1.1.1 Global Oral Market Size and Growth Rate 2018-2023
3.1.1.2 Global Oral Market Size by Region 2018-2023
3.1.2 Injection Market Size 2018-2023
3.1.2.1 Global Injection Market Size and Growth Rate 2018-2023
3.1.2.2 Global Injection Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Oral Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Oral Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Oral Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Injection Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Injection Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Injection Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Hospital Market Size 2018-2023
4.1.1.1 Global Hospital Market Size and Growth Rate 2018-2023
4.1.1.2 Global Hospital Market Size by Region 2018-2023
4.1.2 Clinic Market Size 2018-2023
4.1.2.1 Global Clinic Market Size and Growth Rate 2018-2023
4.1.2.2 Global Clinic Market Size by Region 2018-2023
4.1.3 Others Market Size 2018-2023
4.1.3.1 Global Others Market Size and Growth Rate 2018-2023
4.1.3.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Hospital Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Hospital Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Hospital Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Clinic Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Clinic Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Clinic Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Others Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Infantile Spasms Therapeutics Market Competition
7.1.1 Global Infantile Spasms Therapeutics Market by Companies
7.1.2 Global Infantile Spasms Therapeutics Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 H. Lundbeck
8.1.1 H. Lundbeck Company Profile
8.1.2 H. Lundbeck Product Portfolio
8.1.3 H. Lundbeck Business Performance
8.1.4 H. Lundbeck Development Overview
8.2 Mallinckrodt
8.2.1 Mallinckrodt Company Profile
8.2.2 Mallinckrodt Product Portfolio
8.2.3 Mallinckrodt Business Performance
8.2.4 Mallinckrodt Development Overview
8.3 Insys Therapeutics
8.3.1 Insys Therapeutics Company Profile
8.3.2 Insys Therapeutics Product Portfolio
8.3.3 Insys Therapeutics Business Performance
8.3.4 Insys Therapeutics Development Overview
8.4 Orphelia Pharma
8.4.1 Orphelia Pharma Company Profile
8.4.2 Orphelia Pharma Product Portfolio
8.4.3 Orphelia Pharma Business Performance
8.4.4 Orphelia Pharma Development Overview
8.5 Valerion Therapeutics
8.5.1 Valerion Therapeutics Company Profile
8.5.2 Valerion Therapeutics Product Portfolio
8.5.3 Valerion Therapeutics Business Performance
8.5.4 Valerion Therapeutics Development Overview
8.6 Catalyst Pharmaceuticals
8.6.1 Catalyst Pharmaceuticals Company Profile
8.6.2 Catalyst Pharmaceuticals Product Portfolio
8.6.3 Catalyst Pharmaceuticals Business Performance
8.6.4 Catalyst Pharmaceuticals Development Overview
8.7 Anavex Life Sciences
8.7.1 Anavex Life Sciences Company Profile
8.7.2 Anavex Life Sciences Product Portfolio
8.7.3 Anavex Life Sciences Business Performance
8.7.4 Anavex Life Sciences Development Overview
8.8 Retrophin
8.8.1 Retrophin Company Profile
8.8.2 Retrophin Product Portfolio
8.8.3 Retrophin Business Performance
8.8.4 Retrophin Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
